Pharmacogenetic Analyses of Cisplatin-induced Nephrotoxicity Indicate a Renoprotective Effect of ERCC1 Polymorphisms (Q84916230)

From Wikidata

Jump to navigation Jump to search

scientific article published on 08 September 2011

edit

Language	Label	Description	Also known as
English	Pharmacogenetic Analyses of Cisplatin-induced Nephrotoxicity Indicate a Renoprotective Effect of ERCC1 Polymorphisms	scientific article published on 08 September 2011

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21902499

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21902499%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

title

Pharmacogenetic analyses of cisplatin-induced nephrotoxicity indicate a renoprotective effect of ERCC1 polymorphisms (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21902499

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21902499%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

Pharmacogenetic Analyses of Cisplatin-induced Nephrotoxicity Indicate a Renoprotective Effect of ERCC1 Polymorphisms (English)

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

author

Mladen Vassilev Tzvetkov

series ordinal

1

object named as

Mladen V. Tzvetkov

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21902499

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21902499

retrieved

11 December 2024

Valerie P O'Brien

series ordinal

3

object named as

Valerie P. O'Brien

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21902499

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21902499

retrieved

11 December 2024

author name string

Gerrit Behrens

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21902499

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21902499%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

Karin Hohloch

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21902499

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21902499%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

Jürgen Brockmöller

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21902499

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21902499%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

Peter Benöhr

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21902499

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21902499%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

language of work or name

English

1 reference

stated in

National Center for Biotechnology Information

PubMed publication ID

21902499

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21902499

retrieved

11 December 2024

publication date

8 September 2011

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21902499

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21902499%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

full work available at URL

http://www.futuremedicine.com/doi/abs/10.2217/pgs.11.93

online access status

open access

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21902499

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21902499

retrieved

11 December 2024

https://www.tandfonline.com/doi/pdf/10.2217/pgs.11.93

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

published in

Pharmacogenomics

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21902499

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21902499%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

volume

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21902499

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21902499%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

issue

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21902499

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21902499%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

page(s)

1417-1427

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21902499

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21902499%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

cites work

Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation

1 reference

stated in

COCI

reference URL

https://opencitations.net/index/coci/api/v1/citations/10.1021/BI00324A025

retrieved

21 October 2021

Cisplatin nephrotoxicity

series ordinal

1

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Cisplatin nephrotoxicity: mechanisms and renoprotective strategies

series ordinal

2

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Cystatin C--a marker for assessment of the glomerular filtration rate in patients with cisplatin chemotherapy

series ordinal

3

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Chemotherapy-associated renal dysfunction

series ordinal

4

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Association between long-term neuro-toxicities in testicular cancer survivors and polymorphisms in glutathione-s-transferase-P1 and -M1, a retrospective cross sectional study

series ordinal

5

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Cisplatin-induced long-term hearing impairment is associated with specific glutathione s-transferase genotypes in testicular cancer survivors

series ordinal

6

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Glutathione-S-transferase P1, T1 and M1 genetic polymorphisms in neoadjuvant-treated locally advanced gastric cancer: GSTM1-present genotype is associated with better prognosis in completely resected patients

series ordinal

7

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2

series ordinal

8

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions

series ordinal

9

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Structural determinants of inhibitor interaction with the human organic cation transporter OCT2 (SLC22A2).

series ordinal

10

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family)

series ordinal

11

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

The effects of genetic polymorphisms in the organic cation transporters OCT1, OCT2, and OCT3 on the renal clearance of metformin.

series ordinal

12

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Susceptibility loci involved in cisplatin-induced cytotoxicity and apoptosis

series ordinal

14

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

DNA repair capacity: inconsistency between effect of over-expression of five NER genes and the correlation to mRNA levels in primary lymphocytes

series ordinal

15

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

XPA versus ERCC1 as chemosensitising agents to cisplatin and mitomycin C in prostate cancer cells: role of ERCC1 in homologous recombination repair

series ordinal

16

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.

series ordinal

17

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

ERCC1 codon 118 polymorphism is a predictive factor for the tumor response to oxaliplatin/5-fluorouracil combination chemotherapy in patients with advanced colorectal cancer.

series ordinal

18

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy

series ordinal

19

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.

series ordinal

20

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Relationship between ERCC1 polymorphisms, disease progression, and survival in the Gynecologic Oncology Group Phase III Trial of intraperitoneal versus intravenous cisplatin and paclitaxel for stage III epithelial ovarian cancer

series ordinal

21

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Polymorphisms in ERCC1 and grade 3 or 4 toxicity in non-small cell lung cancer patients.

series ordinal

22

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes

series ordinal

23

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy

series ordinal

24

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Relation Between Renal Dysfunction Requiring Renal Replacement Therapy and Promoter Polymorphism of the Erythropoietin Gene in Cardiac Surgery

series ordinal

25

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications

series ordinal

26

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicity

series ordinal

27

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients

series ordinal

28

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Simplified calculation of body-surface area.

series ordinal

29

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD

series ordinal

30

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Effects of OCT1 polymorphisms on the cellular uptake, plasma concentrations and efficacy of the 5-HT3 antagonists tropisetron and ondansetron

series ordinal

31

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Amelogenin-based sex identification as a strategy to control the identity of DNA samples in genetic association studies

series ordinal

32

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Haploview: analysis and visualization of LD and haplotype maps

series ordinal

33

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

A comparison of bayesian methods for haplotype reconstruction from population genotype data

series ordinal

34

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

New clues for nephrotoxicity induced by ifosfamide: preferential renal uptake via the human organic cation transporter 2.

series ordinal

35

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Influence of Oct1/Oct2-deficiency on cisplatin-induced changes in urinary N-acetyl-beta-D-glucosaminidase

series ordinal

36

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Prediction of fluoroquinolone-induced elevation in serum creatinine levels: a case of drug-endogenous substance interaction involving the inhibition of renal secretion.

series ordinal

37

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Creatinine transport by basolateral organic cation transporter hOCT2 in the human kidney

series ordinal

38

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

SNPs in ERCC1 and drug response to cisplatin in non-small-cell lung cancer patients

series ordinal

39

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

series ordinal

40

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

ERCC1, toxicity and quality of life in advanced NSCLC patients randomized in a large multicentre phase III trial

series ordinal

41

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

A nucleotide polymorphism in ERCC1 in human ovarian cancer cell lines and tumor tissues

series ordinal

42

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

ERCC1 polymorphism, expression and clinical outcome of oxaliplatin-based adjuvant chemotherapy in gastric cancer

series ordinal

44

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Effects of ERCC1 expression in peripheral blood on the risk of head and neck cancer

series ordinal

45

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

A distinct ERCC1 haplotype is associated with mRNA expression levels in prostate cancer patients

series ordinal

46

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

No association of ERCC1 C8092A and T19007C polymorphisms to cancer risk: a meta-analysis

series ordinal

48

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: the Scottish Randomised Trial in Ovarian Cancer

series ordinal

49

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients

series ordinal

50

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Evaluation of an alternate dosing strategy for cisplatin in patients with extreme body surface area values

series ordinal

51

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function

series ordinal

52

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

New loci associated with kidney function and chronic kidney disease

series ordinal

53

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Assessment of cisplatin-induced nephrotoxicity by microarray technology

series ordinal

54

1 reference

stated in

Crossref

DOI

10.2217/PGS.11.93

reference URL

https://api.crossref.org/works/10.2217/PGS.11.93

retrieved

11 December 2024

Identifiers

DOI

10.2217/PGS.11.93

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21902499

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21902499%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

PubMed publication ID

21902499

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21902499

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21902499%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84916230&oldid=2286216057"